Eurartesim (dihydroartemisinin piperaquine tetraphosphate): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro-mobile.jpg?1564492295

Back Back to the list of medications

Medication indications

Eurartesim 320 mg/40 mg film-coated tablets

Eurartesim is indicated for the treatment of uncomplicated Plasmodium falciparum malaria in adults, adolescents, children and infants 6 months and over and weighing 5 kg or more.

Consideration should be given to official guidance on the appropriate use of antimalarial medicinal products.


Route of administration: Oral
Molecule: dihydroartemisinin, piperaquine tetraphosphate

Patients' opinions on Eurartesim

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.